DUALITYBIO-B Plans RMB Share Issuance for STAR Market Listing, Targeting Up to 6.75 Billion Yuan

Stock News04-13 22:50

DUALITYBIO-B (09606) has announced that on April 13, 2026, its board of directors approved a proposed issuance of RMB-denominated shares for listing on the STAR Market, a special authorization, and related matters. The proposal is subject to approval by shareholders at an extraordinary general meeting and the receipt of necessary regulatory approvals. The total funds raised from the RMB share issuance are expected not to exceed 6.75 billion yuan. After deducting issuance expenses, the net proceeds will be used entirely for projects related to the company's main business. The company proposes to issue no more than 15.77919 million RMB shares. The company and the lead underwriter may agree to exercise an over-allotment option, which would allow the issuance of additional RMB shares not exceeding 15% of the initial number of shares to be issued.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1172062646?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-04-13 22:50","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172062646","market":"us","top_or_hot":-1,"title":"DUALITYBIO-B Plans RMB Share Issuance for STAR Market Listing, Targeting Up to 6.75 Billion Yuan","media":"Stock News","content":"<p>DUALITYBIO-B (09606) has announced that on April 13, 2026, its board of directors approved a proposed issuance of RMB-denominated shares for listing on the STAR Market, a special authorization, and related matters. The proposal is subject to approval by shareholders at an extraordinary general meeting and the receipt of necessary regulatory approvals. The total funds raised from the RMB share issuance are expected not to exceed 6.75 billion yuan. After deducting issuance expenses, the net proceeds will be used entirely for projects related to the company's main business. The company proposes to issue no more than 15.77919 million RMB shares. The company and the lead underwriter may agree to exercise an over-allotment option, which would allow the issuance of additional RMB shares not exceeding 15% of the initial number of shares to be issued.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>DUALITYBIO-B Plans RMB Share Issuance for STAR Market Listing, Targeting Up to 6.75 Billion Yuan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDUALITYBIO-B Plans RMB Share Issuance for STAR Market Listing, Targeting Up to 6.75 Billion Yuan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-04-13 22:50</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>DUALITYBIO-B (09606) has announced that on April 13, 2026, its board of directors approved a proposed issuance of RMB-denominated shares for listing on the STAR Market, a special authorization, and related matters. The proposal is subject to approval by shareholders at an extraordinary general meeting and the receipt of necessary regulatory approvals. The total funds raised from the RMB share issuance are expected not to exceed 6.75 billion yuan. After deducting issuance expenses, the net proceeds will be used entirely for projects related to the company's main business. The company proposes to issue no more than 15.77919 million RMB shares. The company and the lead underwriter may agree to exercise an over-allotment option, which would allow the issuance of additional RMB shares not exceeding 15% of the initial number of shares to be issued.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"09606","symbol_name":"映恩生物-B","start_time":0,"source_url":"","article_id":"1172062646","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172062646","pubTimestamp":1776091843,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"DUALITYBIO-B (09606) has announced that on April 13, 2026, its board of directors approved a proposed issuance of RMB-denominated shares for listing on the STAR Market, a special authorization, and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"159982":"中证500","09606":"映恩生物-B","HK0000252152.HKD":"易方达 (香港) 中国股票股息基金A 类 (累积) 港元","HK0000252160.HKD":"易方达 (香港) 中国股票股息基金A 类 (分派) 港元","LU2543165471.USD":"E FUND (HK) GLOBAL QUALITY GROWTH \"A\" (USD) ACC","BK1161":"生物科技","IPOS":"Renaissance International IPO ETF","CYB":"人民币ETF-WisdomTree Dreyfus","HK0000500386.USD":"易方达 (香港) 中国股票股息基金A 类 (累积) 美元"},"translate_title":"DUALITYBIO-B筹划科创板上市人民币股份发行目标最高67.5亿元","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159982":1,"09606":1,"UCmain":1,"IPOS":1,"CYB":1,"MUCmain":1,"CNHmain":1,"MCNHmain":1},"content_text":"DUALITYBIO-B (09606) has announced that on April 13, 2026, its board of directors approved a proposed issuance of RMB-denominated shares for listing on the STAR Market, a special authorization, and related matters. The proposal is subject to approval by shareholders at an extraordinary general meeting and the receipt of necessary regulatory approvals. The total funds raised from the RMB share issuance are expected not to exceed 6.75 billion yuan. After deducting issuance expenses, the net proceeds will be used entirely for projects related to the company's main business. The company proposes to issue no more than 15.77919 million RMB shares. The company and the lead underwriter may agree to exercise an over-allotment option, which would allow the issuance of additional RMB shares not exceeding 15% of the initial number of shares to be issued.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1172062646","isCrawlerRequest":true}